Medtronic PLC  

(Public, NYSE:MDT)   Watch this stock  
Find more results for MDT
+0.06 (0.08%)
Real-time:   3:58PM EDT
NYSE real-time data - Disclaimer
Currency in USD
Range 79.01 - 79.80
52 week 55.54 - 80.74
Open 79.17
Vol / Avg. 3.15M/5.14M
Mkt cap 110.92B
P/E 46.60
Div/yield 0.38/1.91
EPS 1.70
Shares 1.40B
Beta 0.93
Inst. own 85%
Jun 6, 2016
Medtronic PLC Investor Day Add to calendar
May 31, 2016
Q4 2016 Medtronic plc Earnings Release - 9:30AM EDT - Add to calendar
May 31, 2016
Q4 2016 Medtronic PLC Earnings Call - 8:00AM EDT - Add to calendar
Mar 21, 2016
Medtronic PLC at Deutsche Bank MedTech Boot Camp - Webcast
Mar 17, 2016
Medtronic PLC at Barclays Global Healthcare Conference - Webcast
Mar 8, 2016
Medtronic PLC at Cowen Health Care Conference
Mar 1, 2016
Q3 2016 Medtronic plc Earnings Release
Mar 1, 2016
Q3 2016 Medtronic PLC Earnings Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q1 (Jan '16) 2015
Net profit margin 15.79% 13.20%
Operating margin 19.54% 19.62%
EBITD margin - 29.97%
Return on average assets 4.23% 3.70%
Return on average equity 8.52% 7.36%
Employees 92,000 -
CDP Score - 80 D


20 On Hatch, Hatch Street Lower
+353-1-4381700 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Medtronic plc (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine, Neuromodulation, Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. Medtronic, Inc. is a subsidiary of the Company.

Officers and directors

Omar Ishrak Chairman of the Board, Chief Executive Officer
Age: 59
Bio & Compensation  - Reuters
Gary L. Ellis Chief Financial Officer, Senior Vice President, Director
Age: 59
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Carol A. Surface Chief Human Resource Officer, Senior Vice President
Age: 49
Bio & Compensation  - Reuters
Michael J. Coyle Executive Vice President, Group President - Cardiac and Vascular Group
Age: 52
Bio & Compensation  - Reuters
Hooman C. Hakami Executive Vice President and Group President of the Medtronic Diabetes Group
Age: 45
Bio & Compensation  - Reuters
Bryan C. Hanson Executive Vice President, Group President - Minimally Invasive Therapies Group
Age: 48
Bio & Compensation  - Reuters
Robert ten Hoedt Executive Vice President and President, EMEAC
Age: 54
Bio & Compensation  - Reuters
Bradley E. Lerman Senior Vice President, General Counsel, Corporate secretary
Age: 58
Bio & Compensation  - Reuters
Geoffrey S. Martha Senior Vice President - Strategy and Business Development
Age: 45
Bio & Compensation  - Reuters
Richard H. Anderson Lead Independent Director
Age: 60
Bio & Compensation  - Reuters